Starting Now: Be Unstoppable in Managing Venous Thromboembolism

Author(s): Pamela Anderson, Terri Townsend

Contact Hours 1.00

CERP A 1.00

Expires Dec 31, 2025

Topics: MultiSystem

Population: Adult

Role: Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

Acute venous thromboembolism (VTE) is a serious, life-threatening complication for hospitalized patients, and is a principal cause of preventable hospital death. This intermediate session reviews VTE risk factors, guidelines for VTE risk assessment and prophylaxis, when to bridge and processes for prevention of VTE. Indications for pharmacological and mechanical prophylaxis are reviewed. Patient factors influencing anticoagulant dose adequacy are discussed.

Objectives

  • Discuss risk factors associated with the development of venous thromboembolism.
  • Describe a patient factor that affects anticoagulant dosing regimens.
  • List one VTE prevention recommendation from the American College of Chest Physicians.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.